Court Challenges EC's Transparency in 'Pfizergate'

The European Union's highest court has delivered a blow to the European Commission, ruling that it improperly denied access to text messages between EC President Ursula von der Leyen and Pfizer CEO Albert Bourla. These messages, exchanged during the height of the pandemic, are at the heart of allegations surrounding a multibillion-euro vaccine deal.

Evidence Overcomes Presumption of Non-Existence

The Court of Justice of the European Union found the EC's claim of not possessing the texts unconvincing. The New York Times provided compelling evidence that such communications exist, leading the court to annul the EC's decision. This ruling underscores the importance of transparency and accountability in public health decisions.

Implications for Public Trust and Governance

This case, dubbed 'Pfizergate,' raises significant questions about the secrecy surrounding negotiations for COVID-19 vaccines. The court's decision may set a precedent for how similar requests for information are handled in the future, potentially reshaping the landscape of governmental transparency.